Private Equity

A green finance firm is investing in gas-powered data centers. Stephen Miller analyzes the $15M deal that reveals the pragmatic, and controversial, future of AI.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Aurora Mobile integrates ShengShu's potent Vidu model, a strategic maneuver to challenge giants like OpenAI and Google by offering a unified, production-ready AI video platform.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

SWI Group's bold acquisition converts crypto infrastructure for AI's voracious appetite, proving that the next digital revolution will be won with raw power.

SWI Group is betting big, acquiring US firm GDA to create a global AI powerhouse. But can it successfully transform former crypto mines into AI brains?

Chaka Khan's partnership with HarbourView isn't just a deal; it's a look into the future of music, where finance and artistry create a new kind of legacy.

New data reveals a shocking AI divide. Mars Petcare brands dominate AI search, while 80% of independent vets have become digitally invisible to pet owners.

New research reveals AI engines are inventing 1 in 5 celebrity deals and warping financial reputations around single events, signaling a new corporate battleground.

With key hires from the semiconductor world and AWS, SambaNova isn't just growing. It's making a high-stakes bet on premium inference and autonomous AI.

Healthcare Triangle secures $3.6M in complex convertible debt to fuel its AI ambitions. We unpack the high-stakes financing and what it means for the future.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

A new financing vehicle aims to de-risk high-integrity carbon projects, but can this "carbon streaming" model unlock Central Asia's climate potential?

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

Lundin Gold just spun off its silver asset into a new company, LunR Royalties, rewarding shareholders with a special dividend. What does this mean for both firms?

Leveraged finance titans turned a personal fight into a philanthropic powerhouse, raising a record $4.3M to fund the science that’s turning the tide on melanoma.

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.

A major advisory firm's Quebec expansion isn't just a deal. It's a blueprint for growth that values local expertise over brute force. Here's why it matters.

With its $30M purchase of CareSeed, Sagility is betting on AI-driven analytics to move beyond compliance and redefine healthcare quality and financial outcomes.

Dynasty Financial Partners acquires consulting firm Optima Group, betting that a fully integrated platform of tech, capital, and strategy is the future of RIA support.